CNSide Diagnostics
Healthcare Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Cnside Diagnostics Llc's Lab, Houston, T...Website
www.cnside-dx.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About CNSide Diagnostics
CNSide Diagnostics, LLC is dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays, specifically the CNSide CSF assay, designed for patients with Leptomeningeal Metastases. This innovative platform provides healthcare providers with valuable insights through the quantitative analysis and molecular characterization of tumor cells, enhancing patient care and treatment decisions. The company operates a CLIA-registered lab in Houston, Texas, focusing on improving patient outcomes with cutting-edge diagnostics. Their mission is to revolutionize the management of patients suffering from Leptomeningeal Metastases by delivering sensitive and definitive diagnostic solutions.Explore more
Popular SearchesCNSide Diagnostics LLCSIC Code 80,807NAICS Code 62,621Show moreCNSide Diagnostics Org Chart
AB
Interim Chief Marketing Officer, Ad
AS
Finance Chief Financial Officer & Vice Presid...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CNSide Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CNSide Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CNSide Diagnostics recently announced quarterly report
Product Launch: Get notified when CNSide Diagnostics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if CNSide Diagnostics had a recent Job posting/layoffs
Check out if CNSide Diagnostics is spiking on competitors!
Check if CNSide Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CNSide Diagnostics
Funding: Get notified immidiatlly once CNSide Diagnostics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
CNSide Diagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
CNSide Diagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about CNSide Diagnostics.
CNSide Diagnostics Tech Stack
Most Recent Scoops
Person-Based
Person-Based
Partnership, Medical Research
Person-Based
Branding, Corporate Strategy
Person-Based
CNSide Diagnostics News & Media
Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform
Scalable revenue cycle ecosystem designed to support anticipated billing volumes; CNSide assay billing to begin in Q3 2026 with accumulated 2026 backlog of tests and concurrent case billing Scalable revenue cycle ecosystem designed to support anticipated billing volumes; CNSide assay billing to begin in Q3 2026 with accumulated 2026 backlog of tests and concurrent case billingPlus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
Plus Therapeutics will present two posters and host an expert symposium on advancing precision care for CNS metastases at SNO/ASCO 2026.Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
CNSide expands coverage to ~1.2 million people in Ohio and Kentucky, bringing total contracted coverage to approximately 127 million people.Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding CNSide Diagnostics
Sign Up For FreeTo access detailed company insights
CNSide Diagnostics, LLC is dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays, specifically the CNSide CSF assay, designed for patients with Leptomeningeal Metastases. This innovative platform provides healthcare providers with valuable insights through the quantitative analysis and molecular characterizat... Read More
